The Net Margin of Crescent Biopharma Inc (CBIO) is -1438.05%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2025-12-31 | -1438.05% |
| 2024-12-31 | -368994.20% |
| 2023-12-31 | -58362.50% |
| 2022-12-31 | -5468.10% |
| 2021-12-31 | -502.26% |
| 2020-12-31 | -300600.00% |
| 2019-12-31 | -2113.73% |
| 2018-12-31 | -159050.00% |